J Korean Med Sci.  2005 Aug;20(4):704-705. 10.3346/jkms.2005.20.4.704.

Impact of Chlamydia trachomatis and HPV Infection Among Sexually Active Teenage Girls in Upper Silesia, Poland

• Friedek D
• Ekiel A
• Romanik M
• Chelmicki
• Chelmicki
• Martirosian G

• KMID: 1712762
• DOI: http://doi.org/10.3346/jkms.2005.20.4.704

Abstract

No abstract available.

MeSH Terms

Adolescent
Adult
Antigens, Bacterial/analysis
Chlamydia Infections/*diagnosis/epidemiology/microbiology
Chlamydia trachomatis/immunology
DNA, Viral/analysis
Female
Humans
Mass Screening/*methods
Papillomavirus Infections/*diagnosis/epidemiology/virology
Papillomavirus, Human/genetics
Poland/epidemiology
Prevalence
*Sexual Behavior
Urban Population

Reference

1. Lee SJ, Cho YH, Kim CS, Shim BS, Cho IR, Chung JI, Lee JG, Kim ME. Screening for Chlamydia and gonorrhea by strand displacement amplification in homeless adolescents attending youth shelters in Korea. J Korean Med Sci. 2004. 19:495–500.

2. Centers for Disease Control and Prevention (CDC). Chlamydia screening among sexually active young female enrollees of health plans: United States, 1999-2001. MMWR Morb Mortal Wkly Rep. 2004. 53:983–985.

3. Strand RH, Skjeldestad FE, Ovreness T, Nordbo SA. Chlamydia trachomatis; pattern of testing and prevalence among young women. Tidsskr Nor Laegeforen. 2004. 124:1636–1637.

4. Cook RL, Wiesenfeld HC, Ashton MR, Krohn MA, Zamborsky T, Scholle SH. Barriers to screening sexually active adolescent women for chlamydia: a survey of primary care physicians. J Adolesc Health. 2001. 28:204–210.

5. Friedek D, Ekiel A, Chelmicki Z, Romanik M. HPV, Chlamydia trachomatis and genital mycoplasmas infections in women with low grade squamous intraepithelial lesions (LSIL). Ginekol Pol. 2004. 75:457–463.

6. LaMontagne DS, Fenton KA, Randall S, Anderson S, Carter P. Establishing the National Chlamydia Screening Programme in England: results from the first full year of screening. Sex Transm Infect. 2004. 80:335–341.

7. Finan RR, Tamim H, Almawi WY. Identification of Chlamydia trachomatis DNA in human papillomavirus (HPV) positive women with normal and abnormal cytology. Arch Gynecol Obstet. 2002. 266:168–171.

8. Tamim H, Finan RR, Sharida HE, Rashid M, Almawi WY. Cervicovaginal coinfections with human papillomavirus and Chlamydia trachomatis. Diagn Microbiol Infect Dis. 2002. 43:277–281.

9. Anttila T, Saikku P, Koskela P, Bloigu A, Dillner J, Ikaheimo I, Jellum E, Lehtinen M, Lenner P, Hakulinen T, Narvanen A, Pukkala E, Thoresen S, Youngman L, Paavonen J. Serotypes of Chlamydia trachomatis and risk for development of cervical squamous cell carcinoma. JAMA. 2001. 285:47–51.

10. Koskela P, Anttila T, Bjorge T, Brunsvig A, Dillner J, Hakama M, Hakulinen T, Jellum E, Lehtinen M, Lenner P, Luostarinen T, Pukkala E, Saikku P, Thoresen S, Youngman L, Paavonen J. Chlamydia trachomatis infection as a risk factor for invasive cervical cancer. Int J Cancer. 2000. 85:35–39.